[go: up one dir, main page]

AR078226A1 - Derivados de 8-aza-biciclo[3.2,1]octan-3-iloxi-cromen-2- ona, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento del dolor y otros trastornos que responden a la inhibicion de la recaptacion de neurotransmisores de monoamina. - Google Patents

Derivados de 8-aza-biciclo[3.2,1]octan-3-iloxi-cromen-2- ona, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento del dolor y otros trastornos que responden a la inhibicion de la recaptacion de neurotransmisores de monoamina.

Info

Publication number
AR078226A1
AR078226A1 ARP100101689A ARP100101689A AR078226A1 AR 078226 A1 AR078226 A1 AR 078226A1 AR P100101689 A ARP100101689 A AR P100101689A AR P100101689 A ARP100101689 A AR P100101689A AR 078226 A1 AR078226 A1 AR 078226A1
Authority
AR
Argentina
Prior art keywords
aza
bike
derivatives
monoamine neurotransmitters
exo
Prior art date
Application number
ARP100101689A
Other languages
English (en)
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Publication of AR078226A1 publication Critical patent/AR078226A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/468-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Reivindicacion 1: Un compuesto de la formula (1) o una sal farmacéuticamente aceptable del mismo, donde R1 representa H. Reivindicacion 2: El compuesto de acuerdo con la reivindicacion 1, que es exo-7-[(8-aza-biciclo[3,2,1]oct-3-il)oxi]-3-metil-cromen-2-ona, o una sal farmacéuticamente aceptable del mismo. Reivindicacion 3: El compuesto de acuerdo con la reivindicacion 1, que es la sal del ácido clorhídrico de exo-7-[(8-aza-biciclo[3,2,1]oct-3-il)oxi]-3-metil-cromen-2-ona.
ARP100101689A 2009-05-15 2010-05-14 Derivados de 8-aza-biciclo[3.2,1]octan-3-iloxi-cromen-2- ona, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento del dolor y otros trastornos que responden a la inhibicion de la recaptacion de neurotransmisores de monoamina. AR078226A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200900623 2009-05-15

Publications (1)

Publication Number Publication Date
AR078226A1 true AR078226A1 (es) 2011-10-26

Family

ID=42199197

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP100101689A AR078226A1 (es) 2009-05-15 2010-05-14 Derivados de 8-aza-biciclo[3.2,1]octan-3-iloxi-cromen-2- ona, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento del dolor y otros trastornos que responden a la inhibicion de la recaptacion de neurotransmisores de monoamina.

Country Status (12)

Country Link
US (1) US8697721B2 (es)
EP (1) EP2430020B1 (es)
JP (1) JP2012526744A (es)
CN (1) CN102428083A (es)
AR (1) AR078226A1 (es)
AU (1) AU2010247514A1 (es)
BR (1) BRPI1012790A2 (es)
CA (1) CA2760981A1 (es)
MX (1) MX2011011904A (es)
RU (1) RU2011143972A (es)
TW (1) TW201043628A (es)
WO (1) WO2010130620A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130040985A1 (en) 2010-01-29 2013-02-14 Neurosearch A/S Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
WO2012000881A1 (en) * 2010-07-02 2012-01-05 Neurosearch A/S Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
US20120004257A1 (en) * 2010-07-02 2012-01-05 Dan Peters Novel compounds

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE201674T1 (de) 1995-10-13 2001-06-15 Aventis Cropscience Uk Ltd Heterozyclische fungizide
RU2162469C2 (ru) 1995-11-02 2001-01-27 Ньюросерч А/С Конденсированные тропановые производные в качестве ингибиторов обратного захвата нейромедиаторов
SG99853A1 (en) 1996-02-22 2003-11-27 Neurosearch As Tropane-derivatives, their preparation and use
US5916914A (en) 1997-08-08 1999-06-29 Warner-Lambert Company Compounds and method of treating psychosis and schizophrenia
US7538233B2 (en) 2003-09-05 2009-05-26 Aventis Pharmaceuticals Inc. Coumarins as iNOS inhibitors
RU2382040C2 (ru) * 2004-09-30 2010-02-20 НьюроСёрч А/С Новые хромен-2-оновые производные и их применение в качестве ингибиторов обратного захвата моноаминовых нейромедиаторов
EP1828173A1 (en) 2004-12-17 2007-09-05 Neurosearch A/S Enentiomers of 3-heteroaryl-8h-8-azabicyclo(3.2.1)oct-2-ene and their use as monoamine neurotransmitter re-uptake inhibitors
TW200800980A (en) 2006-02-17 2008-01-01 Neurosearch As Novel compounds
US20090312364A1 (en) 2006-12-20 2009-12-17 Neurosearch A/S Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
WO2008074797A1 (en) 2006-12-20 2008-06-26 Neurosearch A/S Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
TW200904815A (en) 2007-05-09 2009-02-01 Neurosearch As Novel compounds
EP2242754A1 (en) 2008-02-05 2010-10-27 NeuroSearch A/S Novel 9-aza-bicyclo[3.3.1]non-3-yloxy chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
WO2011117289A1 (en) 2010-03-25 2011-09-29 Neurosearch A/S Chromen-2-one derivatives and their use as monoamine neuro-transmitter re-uptake inhibitors
US20120004257A1 (en) 2010-07-02 2012-01-05 Dan Peters Novel compounds
WO2012000881A1 (en) 2010-07-02 2012-01-05 Neurosearch A/S Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

Also Published As

Publication number Publication date
EP2430020B1 (en) 2013-10-09
JP2012526744A (ja) 2012-11-01
AU2010247514A1 (en) 2011-11-17
RU2011143972A (ru) 2013-06-20
TW201043628A (en) 2010-12-16
WO2010130620A1 (en) 2010-11-18
CN102428083A (zh) 2012-04-25
EP2430020A1 (en) 2012-03-21
MX2011011904A (es) 2011-12-08
BRPI1012790A2 (pt) 2018-03-13
US20120088789A1 (en) 2012-04-12
US8697721B2 (en) 2014-04-15
CA2760981A1 (en) 2010-11-18

Similar Documents

Publication Publication Date Title
CR11241A (es) Compuestos de pirazol y su uso como inhibidores de raf
NI201200017A (es) Formulación farmacéutica
AR083870A1 (es) Inhibidores de la replicacion del vih
ECSP12012293A (es) Ciertas amino-pirimidinas, composicioines de las mismas y métodos para el uso de los mismos
AR092278A1 (es) Proceso de obtencion de derivados n-acilicos de bifenil-alanina e intermediarios relacionados
MX343264B (es) Ciertas amino-piridazinas, composiciones de las mismas y metodos de uso de los mismos.
AR093659A1 (es) Derivados ciclicos de nucleosidos y usos de los mismos
AR077413A1 (es) Derivados piridin-4-ilo
CY1114689T1 (el) C7-φθορο υποκατεστημενες ενωσεις τετρακυκλινης
CR20140301A (es) Derivados de betulina
CY1118093T1 (el) Φαρμακοτεχνικες μορφες που περιλαμβανουν παραγωγα 1-(bhta-d-γλυκοπυρανοζυλ)-2-θειενυλμεθυλβενζολιου ως αναστολεις sglt
AR072261A1 (es) Derivados piperazin-pirazolicos, composiciones farmaceuticas que los contienen y usos de los mismos como agentes anticancerigenos.
CR20150663A (es) Derivados de diazacarbazol como ligandos de tau para pet
MY172860A (en) Dimethyl-benzoic acid compounds
CR20150419A (es) Derivados sustituidos del ácido bisfenil butanóico fosfónico como inhibidores de la nep
AR057033A1 (es) Tigeciclina y metodos para preparar 9-nitrominociclina
AR087470A1 (es) Derivados imidazolicos bifenilenicos y composiciones farmaceuticas que los contienen
AR081893A1 (es) Derivados de acido 1-(2-fluorobifenil-4-il)-alquil carboxilico para la terapia de la amiloidosis transtiretina
AR078142A1 (es) Compuestos inhibidores heteroarilicos biciclicos de pde4, las composiciones farmaceuticas que los contienen y el uso de los mismos para la preparacion de medicamentos.
AR084505A1 (es) Derivados de 5-metil-1-(naftalen-2-il)-1h-pirazol
AR078226A1 (es) Derivados de 8-aza-biciclo[3.2,1]octan-3-iloxi-cromen-2- ona, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento del dolor y otros trastornos que responden a la inhibicion de la recaptacion de neurotransmisores de monoamina.
CL2024001298A1 (es) Compuestos de cd73
AR088414A1 (es) Derivados sustituidos de indol
MX2014000344A (es) Antagonistas de trpv1 que incluyen sustituyente dihidroxi y sus usos.
ECSP11011081A (es) 3-aminociclopentancarboxamidas

Legal Events

Date Code Title Description
FB Suspension of granting procedure